Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Candyce Kroenke and Bette Caan.
Connection Strength

10.163
  1. Muscle radiodensity and mortality in patients with colorectal cancer. Cancer. 2018 Jul 15; 124(14):3008-3015.
    View in: PubMed
    Score: 0.650
  2. The Importance of Body Composition in Explaining the Overweight Paradox in Cancer-Counterpoint. Cancer Res. 2018 04 15; 78(8):1906-1912.
    View in: PubMed
    Score: 0.645
  3. Next Steps in Understanding the Obesity Paradox in Cancer. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):12.
    View in: PubMed
    Score: 0.590
  4. Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams. JAMA Oncol. 2016 Sep 01; 2(9):1137-45.
    View in: PubMed
    Score: 0.576
  5. Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data. J Natl Cancer Inst. 2016 Mar; 108(3).
    View in: PubMed
    Score: 0.546
  6. Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99.
    View in: PubMed
    Score: 0.485
  7. Re: High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. Response. J Natl Cancer Inst. 2013 Nov 20; 105(22):1761-2.
    View in: PubMed
    Score: 0.472
  8. High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. J Natl Cancer Inst. 2013 May 01; 105(9):616-23.
    View in: PubMed
    Score: 0.453
  9. Social networks, social support, and burden in relationships, and mortality after breast cancer diagnosis in the Life After Breast Cancer Epidemiology (LACE) study. Breast Cancer Res Treat. 2013 Jan; 137(1):261-71.
    View in: PubMed
    Score: 0.443
  10. Social networks, social support and burden in relationships, and mortality after breast cancer diagnosis. Breast Cancer Res Treat. 2012 May; 133(1):375-85.
    View in: PubMed
    Score: 0.421
  11. Differences in Smoking Behavior by Nativity, Race/Ethnicity, and Education Among Women Diagnosed with Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2024 Feb 12.
    View in: PubMed
    Score: 0.241
  12. Individual- and neighborhood-level socioeconomic status and risk of aggressive breast cancer subtypes in a pooled cohort of women from Kaiser Permanente Northern California. Cancer. 2021 Aug 20.
    View in: PubMed
    Score: 0.203
  13. Prediagnosis social support, social integration, living status, and colorectal cancer mortality in postmenopausal women from the women's health initiative. Cancer. 2020 04 15; 126(8):1766-1775.
    View in: PubMed
    Score: 0.182
  14. Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer. JAMA Oncol. 2018 Jun 01; 4(6):798-804.
    View in: PubMed
    Score: 0.163
  15. The Obesity Paradox in Cancer: How Important Is Muscle? Annu Rev Nutr. 2018 08 21; 38:357-379.
    View in: PubMed
    Score: 0.162
  16. The Plausibility of the Obesity Paradox in Cancer-Response-Reply to Point. Cancer Res. 2018 04 15; 78(8):1904-1905.
    View in: PubMed
    Score: 0.161
  17. Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study. JAMA Oncol. 2017 12 01; 3(12):e172319.
    View in: PubMed
    Score: 0.157
  18. Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study. Cancer. 2017 Dec 15; 123(24):4868-4877.
    View in: PubMed
    Score: 0.155
  19. Methodological considerations for disentangling a risk factor's influence on disease incidence versus postdiagnosis survival: The example of obesity and breast and colorectal cancer mortality in the Women's Health Initiative. Int J Cancer. 2017 12 01; 141(11):2281-2290.
    View in: PubMed
    Score: 0.154
  20. Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev. 2017 07; 26(7):1008-1015.
    View in: PubMed
    Score: 0.151
  21. The Optimal Body Mass Index Range for Patients With Colorectal Cancer-Reply. JAMA Oncol. 2017 05 01; 3(5):708.
    View in: PubMed
    Score: 0.151
  22. Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):30-37.
    View in: PubMed
    Score: 0.147
  23. Postdiagnosis social networks and breast cancer mortality in the After Breast Cancer Pooling Project. Cancer. 2017 Apr 01; 123(7):1228-1237.
    View in: PubMed
    Score: 0.147
  24. Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer. J Clin Oncol. 2016 Oct 20; 34(30):3664-3671.
    View in: PubMed
    Score: 0.145
  25. Postdiagnosis Weight Change and Survival Following a Diagnosis of Early-Stage Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):44-50.
    View in: PubMed
    Score: 0.144
  26. Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies. Cancer Res. 2016 09 15; 76(18):5415-22.
    View in: PubMed
    Score: 0.143
  27. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016 08 10; 34(23):2743-9.
    View in: PubMed
    Score: 0.141
  28. Post-diagnosis social networks, and lifestyle and treatment factors in the After Breast Cancer Pooling Project. Psychooncology. 2017 04; 26(4):544-552.
    View in: PubMed
    Score: 0.138
  29. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.131
  30. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
    View in: PubMed
    Score: 0.131
  31. Pre- to post-diagnosis weight change and associations with physical functional limitations in breast cancer survivors. J Cancer Surviv. 2014 Dec; 8(4):539-47.
    View in: PubMed
    Score: 0.123
  32. Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
    View in: PubMed
    Score: 0.121
  33. Social networks, social support mechanisms, and quality of life after breast cancer diagnosis. Breast Cancer Res Treat. 2013 Jun; 139(2):515-27.
    View in: PubMed
    Score: 0.115
  34. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat. 2012 Nov; 136(2):521-33.
    View in: PubMed
    Score: 0.110
  35. Effects of a dietary intervention and weight change on vasomotor symptoms in the Women's Health Initiative. Menopause. 2012 Sep; 19(9):980-8.
    View in: PubMed
    Score: 0.109
  36. Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2012 Aug; 21(8):1260-71.
    View in: PubMed
    Score: 0.108
  37. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1115-25.
    View in: PubMed
    Score: 0.107
  38. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012 Apr; 132(2):729-39.
    View in: PubMed
    Score: 0.104
  39. Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project. Breast Cancer Res Treat. 2012 Jan; 131(2):637-43.
    View in: PubMed
    Score: 0.102
  40. Association between dietary inflammatory potential and mortality after cancer diagnosis in the Women's Health Initiative. Br J Cancer. 2023 Feb; 128(4):606-617.
    View in: PubMed
    Score: 0.056
  41. Weight stability masks changes in body composition in colorectal cancer: a retrospective cohort study. Am J Clin Nutr. 2021 06 01; 113(6):1482-1489.
    View in: PubMed
    Score: 0.050
  42. Low-fat dietary pattern and breast cancer mortality by metabolic syndrome components: a secondary analysis of the Women's Health Initiative (WHI) randomised trial. Br J Cancer. 2021 Aug; 125(3):372-379.
    View in: PubMed
    Score: 0.050
  43. Association of Low Muscle Mass and Low Muscle Radiodensity With Morbidity and Mortality for Colon Cancer Surgery. JAMA Surg. 2020 10 01; 155(10):942-949.
    View in: PubMed
    Score: 0.048
  44. The Association of Abdominal Adiposity With Mortality in Patients With Stage I-III Colorectal Cancer. J Natl Cancer Inst. 2020 04 01; 112(4):377-383.
    View in: PubMed
    Score: 0.046
  45. It's Absolutely Relative: The Effect of Age on the BMI-Mortality Relationship in Postmenopausal Women. Obesity (Silver Spring). 2020 01; 28(1):171-177.
    View in: PubMed
    Score: 0.045
  46. The Effects of Reverse Causality and Selective Attrition on the Relationship Between Body Mass Index and Mortality in Postmenopausal Women. Am J Epidemiol. 2019 10 01; 188(10):1838-1848.
    View in: PubMed
    Score: 0.045
  47. Body Composition and Cardiovascular Events in Patients With Colorectal Cancer: A Population-Based Retrospective Cohort Study. JAMA Oncol. 2019 Jul 01; 5(7):967-972.
    View in: PubMed
    Score: 0.044
  48. Post-cancer diagnosis dietary inflammatory potential is associated with survival among women diagnosed with colorectal cancer in the Women's Health Initiative. Eur J Nutr. 2019 Apr 06.
    View in: PubMed
    Score: 0.043
  49. The association of medical and demographic characteristics with sarcopenia and low muscle radiodensity in patients with nonmetastatic colorectal cancer. Am J Clin Nutr. 2019 Mar 01; 109(3):615-625.
    View in: PubMed
    Score: 0.043
  50. Stratified Probabilistic Bias Analysis for Body Mass Index-related Exposure Misclassification in Postmenopausal Women. Epidemiology. 2018 09; 29(5):604-613.
    View in: PubMed
    Score: 0.041
  51. The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III colorectal cancer: a population-based cohort study (C-SCANS). J Cachexia Sarcopenia Muscle. 2018 Aug; 9(4):664-672.
    View in: PubMed
    Score: 0.041
  52. Associations of pre-existing co-morbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer. J Cachexia Sarcopenia Muscle. 2018 Aug; 9(4):654-663.
    View in: PubMed
    Score: 0.040
  53. The Women's Health Initiative (WHI) Life and Longevity After Cancer (LILAC) Study: Description and Baseline Characteristics of Participants. Cancer Epidemiol Biomarkers Prev. 2018 02; 27(2):125-137.
    View in: PubMed
    Score: 0.040
  54. Association between Post-Cancer Diagnosis Dietary Inflammatory Potential and Mortality among Invasive Breast Cancer Survivors in the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev. 2018 04; 27(4):454-463.
    View in: PubMed
    Score: 0.040
  55. Relationship of prediagnostic body mass index with survival after colorectal cancer: Stage-specific associations. Int J Cancer. 2016 09 01; 139(5):1065-72.
    View in: PubMed
    Score: 0.035
  56. Better postdiagnosis diet quality is associated with reduced risk of death among postmenopausal women with invasive breast cancer in the women's health initiative. Cancer Epidemiol Biomarkers Prev. 2014 Apr; 23(4):575-83.
    View in: PubMed
    Score: 0.030

© 2024 Kaiser Permanente